NEW YORK, Sept 21 – Genomics and proteomics company Genomic Solutions (Nasdaq: GNSL) said Thursday it expects sales of its proteomics tools and services to comprise a greater proportion of revenues in 2000 than in 1999.

“Proteomics is definitely growing,” said Christine Ethier, vice president of the proteomics business unit at Genomic Solutions. “Proteomics accounted for 15 percent of sales last year and this year it will account for 20-25 percent of revenues.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.